Early studies suggest retatrutide may lead to more weight loss than current options, with people losing around 24% of their body weight compared to about 21% with Zepbound and 15% with Wegovy
On the no-membership point, see our no-membership semaglutide guide for how the flat model removes recurring platform fees entirely
We explore the markets dynamic reshaping, the key macro and micro drivers fueling its exponential growth, and the strategic differentiation required for a crowded pipeline
Its once-weekly injection, reduced nausea, and muscle-sparing properties make it a potentially better option than some of the current weight loss drugs on the market, particularly for people with obesity who are also managing blood sugar levels and blood pressure
7: Epitalon Proposed use: Insomnia Proposed form: Subcutaneous injection Performance potential Performance medicine and peptide expert Dr
She says her fridge is full of boxes of Ozempic, Wegovy and Zepbound